1. Home
  2. OGN vs TRS Comparison

OGN vs TRS Comparison

Compare OGN & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.72

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo TriMas Corporation

TRS

TriMas Corporation

BUY

Current Price

$38.91

Market Cap

1.4B

Sector

Industrials

ML Signal

BUY

Company Overview

Basic Information
Metric
OGN
TRS
Founded
1923
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
OGN
TRS
Price
$13.72
$38.91
Analyst Decision
Hold
Buy
Analyst Count
5
2
Target Price
$11.25
★ $45.00
AVG Volume (30 Days)
★ 1.9M
248.9K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
★ 0.58%
0.41%
EPS Growth
N/A
★ 400.00
EPS
0.95
★ 21.96
Revenue
★ $6,216,000,000.00
$645,720,000.00
Revenue This Year
N/A
$4.95
Revenue Next Year
$2.51
$2.79
P/E Ratio
$14.43
★ $1.78
Revenue Growth
★ N/A
N/A
52 Week Low
$5.69
$30.43
52 Week High
$13.79
$45.43

Technical Indicators

Market Signals
Indicator
OGN
TRS
Relative Strength Index (RSI) 53.70 49.89
Support Level $13.46 $38.15
Resistance Level $13.77 $39.91
Average True Range (ATR) 0.04 0.94
MACD -0.00 0.06
Stochastic Oscillator 59.09 47.84

Price Performance

Historical Comparison
OGN
TRS

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About TRS TriMas Corporation

TriMas Corp designs, develops and manufactures a diverse set of products for the consumer products, and industrial markets . The company operates through two segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners. The packaging segment generates majority of its revenue.

Share on Social Networks: